According to new market research from Intel Market Research, the global Embryo Selection Tool market was valued at USD 33.6 million in 2024 and is projected to reach USD 46.5 million by 2031, growing at a steady CAGR of 4.9% during the forecast period (2025-2031). This growth is fueled by widespread adoption of AI-driven fertility solutions, increasing global IVF procedures, and technological advancements in reproductive medicine.
Read MoreAccording to a new report from Intel Market Research, the global Etonogestrel market was valued at USD 852 million in 2024 and is projected to reach USD 1,128 million by 2031, growing at a CAGR of 4.2% during the forecast period (2025-2031). This steady growth is driven by rising demand for hormonal contraceptives, increasing awareness about family planning, and expanding applications in gynecological treatments.
Read MoreAccording to a new report from Intel Market Research, the global oral testosterone market was valued at USD 124 million in 2024 and is projected to reach USD 153 million by 2031, growing at a steady CAGR of 3.1% during the forecast period. This growth trajectory reflects increasing awareness about male hypogonadism and the rising adoption of convenient oral testosterone therapy options.
Read MoreAccording to a comprehensive industry analysis by Intel Market Research, the global Microfiche Scanning Service market was valued at USD 757 million in 2024 and is projected to reach USD 1,104 million by 2031, growing at a steady CAGR of 5.6% during the forecast period (2024-2031). This growth is driven by increasing digitization initiatives across industries, rising demand for document preservation, and the need for efficient information retrieval systems in the digital age.
Read MoreAccording to a new report from Intel Market Research, the global Home Sleep Apnea Testing (HSAT) Tool market was valued at $39.7 million in 2024 and is projected to reach $58.4 million by 2031, growing at a steady CAGR of 5.6% during the forecast period (2024-2031). This growth trajectory reflects escalating demand for cost-effective sleep disorder diagnostics amid rising global sleep apnea prevalence.
Read More